
    
      Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher
      does not know which is active and which is placebo (placebo is actually just versabase gel).
      Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for
      evaluation. Up to 50 patients may be enrolled.
    
  